Stale bread and reheated leftovers: 4-year update of the evolut low risk trial
Commentary on a reanalysis of the 4-year results from the Evolut Low Risk trial, excluding Abbott/St. Jude Trifecta prostheses from the surgical cohort.
Your reference portal for Cardiovascular and Endovascular Surgery.
Previous
Next
If you wish to receive our monthly newsletter, containing all the news collected on our portal, please fill in your email address and click on the “Subscribe” button.